
|Videos|September 21, 2021
ViaLase CEO talks innovations in glaucoma treatment
Author(s)David Hutton, Alex Delaney-Gesing
Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.
Advertisement
Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Moorfields study reveals sharp rise in glaucoma burden across the UK
2
Why individualized glaucoma care remains essential amid uneven patient awareness
3
Study identifies corneal endothelial changes following mRNA COVID-19 vaccination
4
Nanoscope’s gene therapy, MCO-010 receives Sakigake and Orphan Drug Designations in Japan
5














































